Business Description
HTG Molecular Diagnostics Inc
NAICS : 334510
SIC : 3826
ISIN : US40434H1041
Description
HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.65 | |||||
| Equity-to-Asset | 0.04 | |||||
| Debt-to-Equity | 8.38 | |||||
| Debt-to-EBITDA | -0.21 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -35.27 | |||||
| Beneish M-Score | -2.58 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -57.1 | |||||
| 3-Year EBITDA Growth Rate | 34.5 | |||||
| 3-Year EPS without NRI Growth Rate | 35.7 | |||||
| 3-Year FCF Growth Rate | 37.3 | |||||
| 3-Year Book Growth Rate | -68 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.65 | |||||
| 9-Day RSI | 42.84 | |||||
| 14-Day RSI | 44.08 | |||||
| 6-1 Month Momentum % | -87.8 | |||||
| 12-1 Month Momentum % | -93.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | |||||
| Quick Ratio | 1.3 | |||||
| Cash Ratio | 1 | |||||
| Days Inventory | 108.47 | |||||
| Days Sales Outstanding | 64.86 | |||||
| Days Payable | 81.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -90 | |||||
| Shareholder Yield % | 83.98 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 21.69 | |||||
| Operating Margin % | -315.19 | |||||
| Net Margin % | -324.25 | |||||
| ROE % | -421.36 | |||||
| ROA % | -108.43 | |||||
| ROIC % | -229.89 | |||||
| ROC (Joel Greenblatt) % | -730.32 | |||||
| ROCE % | -184.28 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.05 | |||||
| PB Ratio | 0.82 | |||||
| Price-to-Tangible-Book | 0.82 | |||||
| EV-to-EBIT | 0.11 | |||||
| EV-to-EBITDA | 0.12 | |||||
| EV-to-Revenue | -0.35 | |||||
| EV-to-Forward-Revenue | 0.18 | |||||
| EV-to-FCF | 0.12 | |||||
| Earnings Yield (Greenblatt) % | 909.09 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HTGMQ
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HTG Molecular Diagnostics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6.215 | ||
| EPS (TTM) ($) | -17.8 | ||
| Beta | 0.2 | ||
| Volatility % | 93.17 | ||
| 14-Day RSI | 44.08 | ||
| 14-Day ATR ($) | 0.139988 | ||
| 20-Day SMA ($) | 0.28008 | ||
| 12-1 Month Momentum % | -93.75 | ||
| 52-Week Range ($) | 0.16 - 23.64 | ||
| Shares Outstanding (Mil) | 2.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HTG Molecular Diagnostics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HTG Molecular Diagnostics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
HTG Molecular Diagnostics Inc Frequently Asked Questions
What is HTG Molecular Diagnostics Inc(HTGMQ)'s stock price today?
The current price of HTGMQ is $0.18. The 52 week high of HTGMQ is $23.64 and 52 week low is $0.16.
When is next earnings date of HTG Molecular Diagnostics Inc(HTGMQ)?
The next earnings date of HTG Molecular Diagnostics Inc(HTGMQ) is 2023-11-10 Est..
Does HTG Molecular Diagnostics Inc(HTGMQ) pay dividends? If so, how much?
HTG Molecular Diagnostics Inc(HTGMQ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers